Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Ultrasound-Triggered Microbubbles Plus Antibiotics for Knee Infections after Joint Replacement

Official title: Using Ultrasound and Microbubbles to Augment Antibiotic Efficiency Against Periprosthetic Joint Infections

Run by Thomas Jefferson University · NCT07599865 · Data updated 2026-11-12

This study tests whether adding ultrasound-activated microbubbles with antibiotics to the standard revision surgery for knee infections can lower re-infection rates.

More Periprosthetic Joint Infection trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorThomas Jefferson University
Academic / other
Drugs / interventionschemotherapy
Locations3 sites (Philadelphia, Pennsylvania and 2 other locations)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedJune 1, 2029
Study endsJune 1, 2030
Registry record updatedSeptember 23, 2026
Trial IDNCT07599865 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older scheduled for knee revision surgery due to periprosthetic joint infection and who are medically stable.

Probably not a fit

Patients who do not respond to the microbubble therapy or who have contraindications to ultrasound-destructible agents may not see benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In people with an infected knee replacement, participants are randomly assigned to receive the standard surgical treatment with or without an additional ultrasound-activated microbubble therapy and antibiotics within 24 hours of revision. The primary goal is to see if this combination reduces re-infection by at least 24% compared with standard care alone. The trial uses a Phase 2 design to evaluate safety and preliminary effectiveness. Participants must meet specific surgical and health criteria and come from several U.S. centers partnered with Thomas Jefferson University and NIAID.

Why it matters

Potential benefit: If successful, patients may experience fewer reinfections after knee replacement surgery.

How similar studies have gone: This approach is exploratory; prior studies in similar areas have shown potential but results in this exact combination are not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be at least 18 years of age
* Be medically stable
* If female of child-bearing potential, must have a negative pregnancy test
* Be conscious and able to comply with study procedures
* Have read and signed the IRB-approved Informed Consent form for participating in the study
* For Cohort 1, be scheduled for one- or two-stage exchange arthroplasty revision surgery for PJI of the knee
* For Cohort 2, be scheduled for DAIR revision surgery for PJI of the knee

Exclusion Criteria:

* Females who are pregnant or nursing
* Patients currently on chemotherapy requiring systemic infusion treatment
* Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable
* Patients with a history of anaphylactic allergy to perflutren or any other components of Definity
* Patients with a history of failed one- or two-stage revision for infection
* Patients for which placement of a surgical drain is contraindicated
* Patients in protected classes (e.g., prisoners)

Where it's running

  • Thomas Jefferson University/Rothman Institute
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Pittsburgh Medical Center (UPMC)
    Pittsburgh, Pennsylvania, United States
    Not yet recruiting
  • UT Southwestern Medical Center
    Dallas, Texas, United States
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.